1. Lynda Molnar on Study shows bryostatin plays key role in slowing or reversing Alzheimer's disease
    Lynda Molnar Lynda Molnar United States says:
    August 23, 2014 at 1:39 PM

    people wonder why it takes so long to get a drug from discovery to patients. Blanchette Rockefeller Neurological Institute (BRNI) was granted permission by the FDA to begin clinical trial for Bryostatin, June 2009. Here it is more than five years later and they are just beginning a clinical trial. They posted a professional grade video on-line singing the praises of Bryostatin and BRNI being sure to show the name tags of the researchers involved. They received a patent covering the use of Bryostatin to treat alzheimer's disease.  Makes you wonder how badly they really want to find a treatment for AD. Sad to see human beings behave in such a manner.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback